De-Risking Clinical Trials
De-Risk Your Submission
And Protect Your Potential Blockbuster
Machine learning improves data quality and scales to meet increasing demand while identifying patterns across thousands of patients and millions of data points to increase confidence in clinical trial data quality and de-risk submissions. Learn more about how Rave Trial Assurance can help you protect your path to approval.
Improve Data Quality and Inspection Readiness
by avoiding data inconsistencies and submission errors.
Rave Trial Assurance is a managed service by Medidata Solutions that can identify issues with potential regulatory impact and regulatory delay. It combines statistical & machine learning power and the expertise of ex-FDA statistical reviewers to deploy outlier detection across your clinical data. We have deployed over 40 full-service Trial Assurance engagements in pivotal phase 2/3 studies intended for regulatory submission, across 28 Sponsors, 50K+ patients and millions of data points analyzed.
Minimize risk of failure from errors unrelated to drug’s efficacy
Sponsors can refocus on other critical activities and rely on their submission’s data quality to Medidata’s Rave Trial Assurance service.
Protect your path to approval with machine learning driven data quality
Enhance data quality with machine learning to identify and address anomalies that manual review would not
Accelerate time to market using insights from former FDA statistical reviewers
See how Medidata found an average of 61 data quality issues per trial, 22% of which were most likely to delay regulatory approval.